Abstract:Objectives: To evaluate the relationship between levels of serum insulin, the homeostasis model assessment (HOMA) and IGF-binding protein-1 (IGFBP-1) as factors related to myocardial infarction (MI) risk, and their interaction with lifestyle-related risk factors. Design: The Stockholm epidemiology programme (SHEEP), a case-control study, consisting of 749 first-time MI cases (510 men, 239 women) and 1101 healthy controls (705 men, 396 women) was used. Methods: The risk of developing MI was assessed by calculat… Show more
“…Separate analyses, however, showed that waist was significantly negatively correlated to IGFBP-1 in men. 51 A positive correlation between IGFBP-1 and total cholesterol was also found in women, which could be explained by the relationship to HDL cholesterol. 5,6,22,45 The most consistent finding concerning serum lipids was the positive correlation between IGFBP-1 and HDL-C in women.…”
Section: Igfbp-1 and Insulinmentioning
confidence: 93%
“…51 Identifying the extent and causes of sex differences in biochemical, physiological and social outcomes is necessary in understanding variability in susceptibility to a disease and its cause. Men have in general a more disadvantageous cardiovascular risk profile than women.…”
Low circulating levels of IGFBP-1 are associated with the well-known risk factors of cardiovascular disease; however, the association showed a different pattern for men and women. The most marked gender differences in the correlation with IGFBP-1 are seen for testosterone, cortisol, SHBG, WHR, oestradiol, HDL-C and diastolic blood pressure. Our study emphasizes the importance of separate analyses for men and women. The results presented are a step towards gaining a better understanding of the gender differences in cardiovascular disease and in the regulation of IGFBP-1, though further prospective studies are needed.
“…Separate analyses, however, showed that waist was significantly negatively correlated to IGFBP-1 in men. 51 A positive correlation between IGFBP-1 and total cholesterol was also found in women, which could be explained by the relationship to HDL cholesterol. 5,6,22,45 The most consistent finding concerning serum lipids was the positive correlation between IGFBP-1 and HDL-C in women.…”
Section: Igfbp-1 and Insulinmentioning
confidence: 93%
“…51 Identifying the extent and causes of sex differences in biochemical, physiological and social outcomes is necessary in understanding variability in susceptibility to a disease and its cause. Men have in general a more disadvantageous cardiovascular risk profile than women.…”
Low circulating levels of IGFBP-1 are associated with the well-known risk factors of cardiovascular disease; however, the association showed a different pattern for men and women. The most marked gender differences in the correlation with IGFBP-1 are seen for testosterone, cortisol, SHBG, WHR, oestradiol, HDL-C and diastolic blood pressure. Our study emphasizes the importance of separate analyses for men and women. The results presented are a step towards gaining a better understanding of the gender differences in cardiovascular disease and in the regulation of IGFBP-1, though further prospective studies are needed.
“…Total cholesterol, triglycerides and TNFα levels were determined from blood samples drawn by venous puncture undertaken during the health examination as previously described elsewhere [14,15]. Serum samples were stored at − 70°C until analyses for IGFBP-1 and insulin were performed.…”
“…167 Moreover, there may be a synergistic effect of cigarette smoking and insulin resistance in the development of atherosclerosis, suggesting a particularly important role in patients with diabetes mellitus. 168 Smoking cessation interventions should be pursued aggressively, for the benefits in patients with diabetes mellitus at least match those found in patients without diabetes mellitus. 169 A variety of smoking cessation interventions are available, including counseling, nicotine replacement therapy, antidepressants (buproprion), and the nicotine partial receptor agonist, varenicline.…”
Over the last several decades, the global incidence and prevalence of diabetes mellitus has increased significantly. The raised incidence rate is projected to continue as greater numbers of persons adopt a Western lifestyle and diet. Patients with diabetes mellitus are at heightened risk of both adverse microvascular and cardiovascular events. Moreover, once cardiovascular disease develops, diabetes mellitus exacerbates progression and worsens outcomes. The medical management of patients with diabetes mellitus mandates comprehensive risk factor modification and antiplatelet therapy. Recent clinical trials of new medical therapies continue to inform the care of patients with diabetes mellitus to reduce both cardiovascular morbidity and mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.